Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00611104 · ClinicalTrials.gov registry record
Studying the Effect of Freeze-Dried Table Grape Powder on Blood Estrogen Levels in Postmenopausal Women
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 20
- Enrollment target
NCT00611104: Completed study, sponsored by Mayo Clinic.
NCT00611104 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00611104 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
RATIONALE: Estrogen can cause the growth of breast cancer cells. Studying samples of blood and urine in the laboratory from participants receiving freeze-dried table grape powder may help doctors understand the effect of this drug on blood estrogen levels. PURPOSE: This clinical trial is studying the effect of freeze-dried table grape powder on blood estrogen levels in postmenopausal women.
Interventions
- OTHER laboratory biomarker analysis
- OTHER pharmacological study
- DIETARY_SUPPLEMENT standardized freeze-dried table grape powder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2008-08-04 |
| Est. Completion | 2014-08-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00611104
The ClinicalTrials.gov registry entry for NCT00611104 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which laboratory biomarker analysis is the first listed.
NCT00611104 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00611104 about?
NCT00611104 is a clinical study titled "Studying the Effect of Freeze-Dried Table Grape Powder on Blood Estrogen Levels in Postmenopausal Women". RATIONALE: Estrogen can cause the growth of breast cancer cells. Studying samples of blood and urine in the laboratory from participants receiving freeze-dried table grape powder may help doctors understand the effect of this drug on blood estrogen levels. PURPOSE: This clinical trial is studying t...
What is the current status of trial NCT00611104?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2008-08-04. Estimated completion is 2014-08-22.
What interventions are being tested in trial NCT00611104?
The interventions under investigation include: laboratory biomarker analysis (OTHER), pharmacological study (OTHER), standardized freeze-dried table grape powder (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00611104?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.